DESOXIMETASONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Desoximetasone, and what generic alternatives are available?
Desoximetasone is a drug marketed by Actavis Mid Atlantic, Cosette, Fougera Pharms, Lupin, Padagis Israel, Rising, Sciegen Pharms Inc, Zydus Lifesciences, Epic Pharma Llc, Padagis Us, Altana, Glenmark Pharms Ltd, Novel Labs Inc, Pai Holdings Pharm, and The J Molner. and is included in thirty NDAs.
The generic ingredient in DESOXIMETASONE is desoximetasone. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Desoximetasone
A generic version of DESOXIMETASONE was approved as desoximetasone by PADAGIS ISRAEL on July 1st, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DESOXIMETASONE?
- What are the global sales for DESOXIMETASONE?
- What is Average Wholesale Price for DESOXIMETASONE?
Summary for DESOXIMETASONE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 30 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 65 |
| Clinical Trials: | 10 |
| Patent Applications: | 5,007 |
| Drug Prices: | Drug price information for DESOXIMETASONE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DESOXIMETASONE |
| What excipients (inactive ingredients) are in DESOXIMETASONE? | DESOXIMETASONE excipients list |
| DailyMed Link: | DESOXIMETASONE at DailyMed |
See drug prices for DESOXIMETASONE
Recent Clinical Trials for DESOXIMETASONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wake Forest University Health Sciences | Phase 4 |
| Psoriasis Treatment Center of Central New Jersey | Phase 4 |
| SPS MEDICAL CO.,LTD. | Phase 3 |
Pharmacology for DESOXIMETASONE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for DESOXIMETASONE
Anatomical Therapeutic Chemical (ATC) Classes for DESOXIMETASONE
Paragraph IV (Patent) Challenges for DESOXIMETASONE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| TOPICORT | Topical Spray | desoximetasone | 0.25% | 204141 | 1 | 2013-12-18 |
US Patents and Regulatory Information for DESOXIMETASONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | DESOXIMETASONE | desoximetasone | OINTMENT;TOPICAL | 205206-001 | Sep 19, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lupin | DESOXIMETASONE | desoximetasone | SPRAY;TOPICAL | 208124-001 | Mar 16, 2018 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Mid Atlantic | DESOXIMETASONE | desoximetasone | CREAM;TOPICAL | 205082-001 | Sep 4, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Epic Pharma Llc | DESOXIMETASONE | desoximetasone | OINTMENT;TOPICAL | 201005-001 | Apr 24, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Padagis Israel | DESOXIMETASONE | desoximetasone | OINTMENT;TOPICAL | 077770-001 | Apr 20, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | DESOXIMETASONE | desoximetasone | CREAM;TOPICAL | 210980-001 | Dec 21, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
